NCT00006682View on ClinicalTrials.gov

Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2000

Primary Completion Date

January 22, 2002

Study Completion Date

January 22, 2002

Conditions
Breast Cancer
Interventions
DRUG

docetaxel

Docetaxel 70mg/m2 on day 1 of every 21-day cycle

DRUG

vinorelbine ditartrate

Navelbine 20mg/m2 on Day 1 and D8 of a 21-day cycle

Trial Locations (2)

20010

Washington Cancer Institute, Washington D.C.

Washington Hospital Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER